Eligibility criteria Inclusion criteria for original articles encompassed: (1) interventional studies (clinical trials, randomized controlled trials) evaluating gastrointestinal adverse events associated with GLP-1 RAs in non-diabetic patients with overweight or obesity
The supernatant was collected and doubly filtered (with a glass filter and then with a PVDF filter)
Tolerability and a smooth ramp-up are priorities
To the authors knowledge, this case marked the first reported case of acute functional gastric outlet obstruction associated with tirzepatide. Why this matters for you: Its important to recognize severe symptoms so you can have an informed perspective on what youre feeling when you take a medication like tirzepatide
Consumers, researchers, and institutions are advised to consult directly with the manufacturer or appropriate regulatory authorities for any questions regarding legality, usage restrictions, or safety protocols before purchasing or handling any research compound
GLP-1 anti-obesity medicines remain too expensive March 31, 2025 Summary: Researchers model shows that GLP-1 drugs offer enormous clinical benefits, but they are not cost-effective at current price